Sepsis Alliance AMR Conference 2023
Here, you can register for the Sepsis Alliance AMR Conference recordings in one package. If you would like to review individual sessions, you can do so here.
Advanced Search This List
-
Recorded On: 04/27/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Sustainable resources are needed to improve antibiotic stewardship in healthcare facilities across the country. Healthcare professionals and networks can solve gaps that worsen known health inequities in antibiotic prescribing and use by implementing data-driven solutions, sharing knowledge, and integrating resources. This keynote session will discuss current policy efforts that aim to improve antibiotic stewardship practices and economic incentive policies.
Learning Objectives:
At the end of the session, the learner should be able to:
- Understand how both improving the development pipeline for new antibiotics and ensuring optimal use of existing ones are integral to combatting antimicrobial resistance;
- Discuss how policies can help spur the adoption of antibiotic stewardship practices across healthcare settings;
- Describe how economic incentive policies aim to help revitalize the antibiotic pipeline.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
David Hyun, MD
Project Director of the Antibiotic Resistance Project
The Pew Charitable Trusts
David Hyun, MD, directs Pew’s antibiotic resistance project, which supports policies that remove regulatory, economic, and scientific obstacles to the discovery of new antibiotics and ensures that antibiotics are prescribed only when necessary.
Before joining Pew, he practiced medicine at Children’s National Medical Center, where he developed and co-chaired the antibiotic stewardship program. He also was an assistant professor of pediatrics at George Washington University School of Medicine. Dr. Hyun has published and lectured widely on managing antibiotic use in inpatient and outpatient settings.
Dr. Hyun received a bachelor’s degree in chemistry from the University of Minnesota and a Doctor of Medicine from Ohio State University’s College of Medicine. He completed his residency in pediatrics at Indiana University and a fellowship program in pediatric infectious disease at Baylor College of Medicine.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
This session will cover two important CDC initiatives that are designed to combat AMR and sepsis respectively. Participants will gain a comprehensive understanding of the implementation, uptake, and future direction of the Core Elements of Hospital Antibiotic Stewardship Programs. Additionally, participants will be introduced to the forthcoming CDC Core Elements of Hospital Sepsis Programs, including a preview of the program’s scope and purpose.
Learning Objectives:
At the end of the session, the learner should be able to:
- Discuss Core Elements of Hospital Antibiotic Stewardship Programs implementation, uptake, and future direction;
- Describe the scope and purpose of the upcoming CDC Core Elements of Hospital Sepsis Programs;
- Preview components of the Sepsis Core Elements.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Melinda Neuhauser, PharmD, MPH
Pharmacist and Acute Care Lead
Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC)
Melinda Neuhauser, PharmD, MPH, FCCP, FASHP, FIDP is pharmacist and Acute Care Lead for Centers for Disease Control and Prevention (CDC) Office of Antibiotic Stewardship in the Division of Healthcare Quality Promotion. Dr. Neuhauser earned a Doctor of Pharmacy from the University of Minnesota College of Pharmacy and a Master in Public Health from Johns Hopkins Bloomberg School of Public Health. She also completed an infectious diseases residency at Detroit Receiving Hospital and infectious diseases fellowship at University of Illinois at Chicago.
Raymund Dantes, MD, MPH
Associate Professor of Medicine
Emory University School of Medicine
Raymund Dantes, MD, MPH, is an Associate Professor of Medicine at the Emory University School of Medicine, where he practices hospital medicine. He is also on the Sepsis Leadership Committee for Emory Healthcare. Dr. Dantes works on many sepsis-related activities for the CDC and serves as a medical advisor to the CDC's National Healthcare Safety Network, where he leads research and development efforts of new healthcare quality measures in the pipeline.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.7 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Artificial intelligence (AI) has been increasingly applied in medicine and, in particular, in the development of new drugs to combat antimicrobial resistance (AMR). AI can serve as a new tool to shorten drug development time and costs in the development of new therapeutics and antibiotics. During this session, the presenter will discuss the use of AI to combat AMR and other infections that can lead to sepsis and the importance of the accelerated development of new drugs.
Learning Objectives:
At the end of the session, the learner should be able to:
- Summarize the basics of AI and other forms of computing;
- List the ways in which AI can be leveraged to combat AMR;
- Identify how AI can be used to drastically reduce the time and cost to discover new drugs.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Supratik Mukhopadhyay, PhD
Professor, Department of Environmental Sciences
Louisiana State University
Supratik Mukhopadhyay, PhD, is a full Professor at the Center for Computation & Technology (CCT) at Louisiana State University (LSU). Professor Mukhopadhyay led the DeepDrug team (DeepDrug (lsu.edu)) for automated drug discovery using Artificial Intelligence to the semifinals of AI XPRIZE (among 147 teams worldwide), the world’s top competition for using AI for solving moonshot challenges (DeepDrug | AI XPRIZE). Combination therapy discovered by the DeepDrug Artificial Intelligence Platform for COVID-19 has undergone human studies at the Riverside University Health System, California (Riverside University Health System Medical Center, Skymount Medical Begin U.S. Clinical Trial for COVID-19 Oral Therapeutics Discovered Using Artificial Intelligence | County of Riverside (rivco.org)) and in Ukraine. The platform took 13 months from inception to human studies, which is one of the fastest in the pharmaceutical world for combination therapy. DeepDrug has also been approved for human trials by MHRA in the United Kingdom (Skymount Medical Receives UK MHRA Approval to Test New (globenewswire.com)). DeepDrug is the world’s only AI platform to discover a nutraceutical and bring it to market (Home - Inhibinol).
Apart from Drug Discovery, Professor Mukhopadhyay has worked on AI for environmental challenges, education, port and supply chain security, satellite image understanding, video and image analytics, design of intelligent buildings and transportation systems, wildfire prediction and detection, conservation of endangered species and intelligent cyber-physical-human systems, to name a few. His DeepSat framework for satellite imagery understanding forms the basis of NASA Earth Exchange (NEX) (see DeepSAT: A Deep Learning Approach to Tree-Cover Delineation in 1-m NAIP Imagery for the Continental United States - NASA Technical Reports Server (NTRS)).
In the last 13 years, Professor Mukhopadhyay has received more than $9 million in research grants. His research has been funded by the NSF, DARPA, ARO, ONR, NGA, NASA, DOE, USDOT, USDA, NRL, state agencies, and private industry. Professor Mukhopadhyay has published around 125 refereed publications in reputed journals and conferences. He has been awarded 3 US Patents and has 8 US patents pending. Additionally, he has received numerous awards for his research and cofounded a startup, Ailectric, for commercializing his research on sound, video, and image analytics (Ailectric | Home | Artificial Intelligence | Deep Learning). He serves as an associate editor for IEEE Transactions on Artificial Intelligence and Remote Sensing letters and has served in the program committees of AAAI.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Antimicrobial Resistance (AMR) is a complex issue that needs to be tackled with a systems thinking approach, and interdisciplinary collaboration is key. The One Health Approach establishes that the health of humans, domestic and wild animals, plants, and the wider environment (including ecosystems) are closely linked and inter-dependent. Therefore, AMR should be addressed with a One Health approach in mind.
Animal health can broadly be divided into two sectors. The first sector is animal agriculture where a population medicine approach is used to address animal health issues, and where the main objective is to provide nutritious and healthy safe animal protein for the consumers.
In this session, attendees will gain an understanding of the veterinary perspective on ‘One Health’ system thinking, as well as learn about the current challenges and opportunities for antimicrobial stewardship in animal health, and how that ultimately affects the lives of humans.
Learning Objectives:
At the end of the session, the learner should be able to:
- Understand One Health from the veterinary perspective;
- Review the challenges around antibiotic use in animal health;
- Describe opportunities for antimicrobial stewardship in animal health.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Lucas Pantaleon DVM, MBA
Veterinary Industry Advisor
DVM One Health
Lucas Pantaleon, DVM, MBA, is a veterinarian and Board-Certified Large Animal Internal Medicine Specialist. He also holds an MBA and is the founder of DVM One Health. He works with companies and individuals to implement strategies to improve animal health by focusing on antibiotic use, infection prevention, One Health, and Value-Based veterinary care concepts in different sectors of animal health. Dr. Pantaleon also practices small animal general medicine. He is involved in different committees, councils, and Boards, working to better the health of pets and livestock. He enjoys researching, advising, teaching, speaking, and writing about infection prevention, AMR, and One Health for varied sectors within the veterinary industry and beyond. He lives in Kentucky with his wife and twin daughters.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Much of the focus of Antimicrobial Stewardship programs has been on optimizing use of antibiotics in bacterial infections. However, with the rising rates of antifungal resistance, antifungal stewardship is also necessary. Unlike antibacterial drugs, there are only a limited number of drugs available to treat invasive fungal infections. In this session, the audience will learn about the current epidemiology of antifungal resistance worldwide, the current limitations of antifungal therapy, the effects of COVID-19 pneumonia on the risk of fungal infections, and what antifungal stewardship steps could limit the rise of antifungal resistance.
Learning Objectives:
At the end of the session, the learner should be able to:
- Discuss the epidemiology of antifungal resistance and how it affects human health;
- Identify the main drivers for the increasing trend in antifungal resistance;
- Describe preventative measures to curb the development of antifungal resistance.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Emi Minejima, PharmD
Associate Professor of Clinical Pharmacy
USC School of Pharmacy
Dr. Minejima received her PharmD degree from University of California, San Diego Skaggs School of Pharmacy in 2005 and completed both her residency training in pharmacy practice and infectious diseases pharmacotherapy at Huntington Hospital in Pasadena, CA. After residency, she joined the faculty at the University of Southern California, School of Pharmacy where she is currently an Associate Professor of Clinical Pharmacy. Her clinical practice is based at Los Angeles County/USC Medical Center where she helps run the antimicrobial stewardship program and is the director for PGY2 infectious diseases residency program. Her research interests include S. aureus infections and optimizing the use of antibiotics to improve care for the medically underserved population.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Antimicrobial stewardship is an important strategy to address the public health crisis of antimicrobial resistance. The emergence of telemedicine's use in a variety of innovative ways, especially during the COVID-19 pandemic, has allowed for antimicrobial stewardship programs to be implemented in settings with limited resources. In this session, the presenter will discuss the role of antimicrobial stewardship and its impact on antimicrobial resistance. Additionally, the presenter will provide a better understanding of telemedicine’s impact on antimicrobial usage.
Learning Objectives:
At the end of the session, the learner should be able to:
- Describe the role of antimicrobial stewardship on the impact of AMR;
- Understand the role of telemedicine on antimicrobial usage.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP
Chair of the Infectious Disease Division and Co-Director of Antimicrobial Stewardship
Summa Health
Thomas File, MD, MSc, MACP, FIDSA, FCCP, is Chair of the Infectious Disease Division and Co-Director of Antimicrobial Stewardship at Summa Health in Akron, Ohio. He is also a professor of Internal Medicine, Master Teacher, and Chair of the Infectious Disease Section at Northeast Ohio Medical University. After graduating from medical school at the University of Michigan, Ann Arbor, Dr. File received his Master of Science in medical microbiology from Ohio State University in Columbus, where he also completed his fellowship in infectious diseases.
Dr. File is a past President of the Board of Directors of the Infectious Diseases Society of America (IDSA) and Past President of the National Foundation for Infectious Diseases (NFID). He is a Master of the American College of Physicians, a fellow of the American College of Chest Physicians, and a member of the American Thoracic Society. He is also a past Chairperson of the Standards and Practice Guidelines Committee of the IDSA and served as a member of several guideline panels. Additionally, he is a past-president of the Infectious Disease Society of Ohio.
Dr. File’s primary research interests include respiratory tract infections, antimicrobial stewardship, immunizations in adults, and evaluation of new antimicrobial agents. A frequent lecturer, nationally and internationally, he has published more than 250 articles, abstracts, and textbook chapters, focusing on the diagnosis, etiology, and treatment of infectious diseases, especially on respiratory tract infections and antimicrobial stewardship. He received the Watanakunakorn Clinician Award from the IDSA in 2013 and the John P Utz Leadership award from NFID in 2017. He authors sections on community-acquired pneumonia, acute bronchitis, and hospital-acquired pneumonia in UpToDate. Dr. File is currently Editor-in-Chief of Infectious Diseases in Clinical Practice.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Antimicrobial stewardship programs (ASPs) are a key component of addressing the global AMR threat. Optimizing the use and duration of in-hospital antimicrobials, along with organizational prioritization and buy-in, are just a few of the ASP strategies that can help lessen the burden of AMR.
The presenter will share more about the purpose of implementing an in-hospital ASP and discuss interventions that can be applied to improve antibiotic use, limiting AMR. Opportunities for how to align and integrate hospital sepsis programs with the ASP will also be discussed.
Learning Objectives:
At the end of the session, the learner should be able to:
- Understand the purpose of implementing an antimicrobial stewardship program in the hospital setting;
- Outline ASP interventions that can be applied to improve antibiotic use and limit antibiotic resistance;
- Discuss opportunities to align and integrate the hospital sepsis program with the ASP.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Nikunj Vyas, PharmD, BCPS
Clinical Pharmacist/Infectious Diseases
Jefferson Health - New Jersey
Nikunj Vyas, PharmD, BCPS, is a Clinical Pharmacy Specialist in Infectious Diseases currently practicing at Jefferson Health – New Jersey. He received his Doctorate of Pharmacy from St. John’s University in New York City in 2012. He then went on to complete a Pharmacy Practice Residency at Atlantic Health System in Morristown, NJ and Infectious Diseases Pharmacy Residency at West Virginia University Healthcare in Morgantown, West Virginia.
At Jefferson Health – New Jersey, Dr. Vyas oversees infectious disease pharmacotherapy and co-chairs the Antimicrobial Stewardship Committee, in collaboration with Infectious Diseases service. He also serves as a preceptor and mentor to post-doctoral pharmacy residents and students from numerous pharmacy schools. Additionally, Dr. Vyas serves as a member on numerous committees including the Sepsis Committee, the Infection Control Committee, and the Pharmacy and Therapeutics Committee, where he represents the Antimicrobial Stewardship Program and the Clinical Pharmacy Department.
Dr. Vyas is also well published in gram positive and gram-negative resistant organisms, as well as antimicrobial stewardship strategies in an inpatient setting. He has continued interest in patient quality and safety as well as clinical outcome-based research.
Dr. Vyas was awarded the Pharmacy Practitioner of the Year for the state of New Jersey in 2018 by New Jersey Health System Pharmacists. This big honor was for his dedication to Antimicrobial Stewardship and optimizing patient care. In his free time, Dr. Vyas is a sports fanatic and loves to travel and try different cuisines around the world.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
During this keynote session, Brad Spellberg, MD, a physician, researcher, and published author will discuss the scope of antimicrobial resistance in the 21st century. Dr. Spellberg will review the fundamental drivers of inappropriate antibiotic prescriptions and present some of his innovative solutions for improving antibiotic prescriptions.
Learning Objectives:
At the end of the session, the learner should be able to:
- Understand the scope of the antibiotic resistance problem;
- Learn the fundamental drivers of inappropriate antibiotic prescriptions;
- Learn some innovative solutions to improve antibiotic prescriptions.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Brad Spellberg, MD
Chief Medical Officer
LAC+USC Medical Center
Brad Spellberg, MD, is Chief Medical Officer (CMO) at the Los Angeles County-University of Southern California (LAC+USC) Medical Center. Dr. Spellberg has extensive administrative, patient care, and teaching activities. As CMO of LAC+USC Medical Center, one of the largest public hospitals in the U.S., he works to continuously improve the quality, safety, and efficiency of provided care. At LAC+USC Dr. Spellberg works on the Internal Medicine ward teams, Infectious Disease consulting service, and the Antibiotic Stewardship service. He also maintains an active NIH-funded basic science laboratory that focuses on novel solutions to combatting antibiotic–resistant infections. At the national level, Dr. Spellberg has worked extensively to bring attention to the problems of increasing drug resistance and decreasing new antibiotics. He works to raise attention of the need for national healthcare reform. Dr. Spellberg has testified before Congress and participated in numerous national meetings on antibiotic resistant superbugs and how to combat them, and has appeared in numerous media outlets discussing this issue. In 2009, he published the book Rising Plague to inform and educate the public about the crisis in antibiotic-resistant infections and lack of antibiotic development. His latest book, Broken, Bankrupt, and Dying: How to Solve the Great American Healthcare Rip-Off, was published in June 2020.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.9 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
With antimicrobial resistance as a growing global health concern, healthcare professionals across the continuum of care must educate themselves. Home healthcare nurses play an integral part in teaching their patients and their caregivers about preventing infection, conducting thorough assessments for infections, and collecting cultures as needed. In this session, the presenter will review and define antimicrobial resistance and stewardship globally and as it relates to the homecare setting. Attendees will also learn about antimicrobial stewardship strategies and responsibilities for the home healthcare nurse.
Learning Objectives:
At the end of the session, the learner should be able to:
- Identify the problem of antimicrobial resistance;
- Define antimicrobial stewardship (AMS);
- Examine AMS functions for the home healthcare nurse.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Lisa A. Gorski RN, MS, HHCNS-BC, CRNI, FAAN
Clinical Education Specialist
Ascension at Home
Lisa A. Gorski, RN, MS, HHCNS-BC, CRNI, FAAN has worked for over 35 years as a clinical nurse specialist (CNS) and educator for Wheaton Franciscan Home Health & Hospice, now part of Ascension at Home. She received both her bachelor's and master's degrees from the University of Wisconsin-Milwaukee College of Nursing.
Lisa is the author of more than 70 book chapters and journal articles and is the author of several books, including the 2023 edition of the Phillips Manual of IV Therapeutics: Evidence-Based Practice for Infusion Therapy. Lisa has been actively involved with the Infusion Nurses Society (INS) for many years serving as the chair of the INS Standards of Practice Committee from 2009 to 2021 and is the co-chair for the 2024 Standards. She speaks nationally and internationally on standards development, home healthcare, and infusion therapy/vascular access. She is the co-author of a 2021 article entitled “Antimicrobial Resistance and Antimicrobial Stewardship in Home Healthcare” published in Home Healthcare Now.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
The role of nurses in caring for and improving outcomes for patients with infections and sepsis is well known. Beyond that, nurses can also directly impact antimicrobial resistance (AMR) and antimicrobial stewardship (AMS) through a variety of nurse-driven protocols and practices. These can include thorough assessments and allergy documentation, a questioning attitude towards culturing, evidence-based culturing techniques, and consideration for antimicrobial duration and route of administration. In this session, attendees will learn about the nurse’s role and responsibility in AMR and AMS, gain an understanding of opportunities and barriers to nurses’ engagement in AMS across the continuum of care, and examine key strategies to empower nurses’ ownership, accountability, and contribution to the core elements of AMS.
Learning Objectives:
At the end of the session, the learner should be able to:
- Discuss the nurse’s role and responsibility in AMR and AMS;
- Understand opportunities and barriers to nurses’ engagement in AMS across the continuum of care;
- Review key strategies to empower nurses’ ownership, accountability, and contribution to the core elements of antimicrobial stewardship.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Rita Olans, DNP, CPNP-PC, SNP, FAAN, FNAP
Associate Professor and Pediatric Track Coordinator, School of Nursing
MGH Institute of Health Professions
Rita Olans, DNP, CPNP-PC, SNP, FAAN, FNAP is a nationally recognized leader on nurses’ contributions to antimicrobial stewardship. She has authored numerous publications in nursing and medical literature and is a contributor to the National Quality Partners Playbooks for Antimicrobial Stewardship in Acute Care, in Post-Acute, and in Long-Term Care. Dr. Olans also served as a technical expert to the Agency for Healthcare Research and Quality Comprehensive Unit-based Safety Programs for Antimicrobial Stewardship in Acute Care and in Ambulatory Settings. She was a co-author of the ANA/CDC White Paper defining the nurse’s role in stewardship. She has been invited by The Joint Commission, the Pew Charitable Trust, the Centers for Disease Control and Prevention, the American Hospital Association, and the National Quality Forum to address how nurses contribute to antimicrobial stewardship. She is also a frequent presenter to physicians, nurses, nurse practitioners, pharmacists, microbiologists, public health officials, and regulatory agencies.
Dr. Olans is an Associate Professor at the MGH Institute of Health Professions and a Fellow of the American Academy of Nursing.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/27/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Sustainable resources are needed to improve antibiotic stewardship in healthcare facilities across the country. Healthcare professionals and networks can solve gaps that worsen known health inequities in antibiotic prescribing and use by implementing data-driven solutions, sharing knowledge, and integrating resources. This keynote session will discuss current policy efforts that aim to improve antibiotic stewardship practices and economic incentive policies.
Learning Objectives:
At the end of the session, the learner should be able to:
- Understand how both improving the development pipeline for new antibiotics and ensuring optimal use of existing ones are integral to combatting antimicrobial resistance;
- Discuss how policies can help spur the adoption of antibiotic stewardship practices across healthcare settings;
- Describe how economic incentive policies aim to help revitalize the antibiotic pipeline.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
David Hyun, MD
Project Director of the Antibiotic Resistance Project
The Pew Charitable Trusts
David Hyun, MD, directs Pew’s antibiotic resistance project, which supports policies that remove regulatory, economic, and scientific obstacles to the discovery of new antibiotics and ensures that antibiotics are prescribed only when necessary.
Before joining Pew, he practiced medicine at Children’s National Medical Center, where he developed and co-chaired the antibiotic stewardship program. He also was an assistant professor of pediatrics at George Washington University School of Medicine. Dr. Hyun has published and lectured widely on managing antibiotic use in inpatient and outpatient settings.
Dr. Hyun received a bachelor’s degree in chemistry from the University of Minnesota and a Doctor of Medicine from Ohio State University’s College of Medicine. He completed his residency in pediatrics at Indiana University and a fellowship program in pediatric infectious disease at Baylor College of Medicine.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
This session will cover two important CDC initiatives that are designed to combat AMR and sepsis respectively. Participants will gain a comprehensive understanding of the implementation, uptake, and future direction of the Core Elements of Hospital Antibiotic Stewardship Programs. Additionally, participants will be introduced to the forthcoming CDC Core Elements of Hospital Sepsis Programs, including a preview of the program’s scope and purpose.
Learning Objectives:
At the end of the session, the learner should be able to:
- Discuss Core Elements of Hospital Antibiotic Stewardship Programs implementation, uptake, and future direction;
- Describe the scope and purpose of the upcoming CDC Core Elements of Hospital Sepsis Programs;
- Preview components of the Sepsis Core Elements.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Melinda Neuhauser, PharmD, MPH
Pharmacist and Acute Care Lead
Office of Antibiotic Stewardship, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC)
Melinda Neuhauser, PharmD, MPH, FCCP, FASHP, FIDP is pharmacist and Acute Care Lead for Centers for Disease Control and Prevention (CDC) Office of Antibiotic Stewardship in the Division of Healthcare Quality Promotion. Dr. Neuhauser earned a Doctor of Pharmacy from the University of Minnesota College of Pharmacy and a Master in Public Health from Johns Hopkins Bloomberg School of Public Health. She also completed an infectious diseases residency at Detroit Receiving Hospital and infectious diseases fellowship at University of Illinois at Chicago.
Raymund Dantes, MD, MPH
Associate Professor of Medicine
Emory University School of Medicine
Raymund Dantes, MD, MPH, is an Associate Professor of Medicine at the Emory University School of Medicine, where he practices hospital medicine. He is also on the Sepsis Leadership Committee for Emory Healthcare. Dr. Dantes works on many sepsis-related activities for the CDC and serves as a medical advisor to the CDC's National Healthcare Safety Network, where he leads research and development efforts of new healthcare quality measures in the pipeline.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.7 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Artificial intelligence (AI) has been increasingly applied in medicine and, in particular, in the development of new drugs to combat antimicrobial resistance (AMR). AI can serve as a new tool to shorten drug development time and costs in the development of new therapeutics and antibiotics. During this session, the presenter will discuss the use of AI to combat AMR and other infections that can lead to sepsis and the importance of the accelerated development of new drugs.
Learning Objectives:
At the end of the session, the learner should be able to:
- Summarize the basics of AI and other forms of computing;
- List the ways in which AI can be leveraged to combat AMR;
- Identify how AI can be used to drastically reduce the time and cost to discover new drugs.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Supratik Mukhopadhyay, PhD
Professor, Department of Environmental Sciences
Louisiana State University
Supratik Mukhopadhyay, PhD, is a full Professor at the Center for Computation & Technology (CCT) at Louisiana State University (LSU). Professor Mukhopadhyay led the DeepDrug team (DeepDrug (lsu.edu)) for automated drug discovery using Artificial Intelligence to the semifinals of AI XPRIZE (among 147 teams worldwide), the world’s top competition for using AI for solving moonshot challenges (DeepDrug | AI XPRIZE). Combination therapy discovered by the DeepDrug Artificial Intelligence Platform for COVID-19 has undergone human studies at the Riverside University Health System, California (Riverside University Health System Medical Center, Skymount Medical Begin U.S. Clinical Trial for COVID-19 Oral Therapeutics Discovered Using Artificial Intelligence | County of Riverside (rivco.org)) and in Ukraine. The platform took 13 months from inception to human studies, which is one of the fastest in the pharmaceutical world for combination therapy. DeepDrug has also been approved for human trials by MHRA in the United Kingdom (Skymount Medical Receives UK MHRA Approval to Test New (globenewswire.com)). DeepDrug is the world’s only AI platform to discover a nutraceutical and bring it to market (Home - Inhibinol).
Apart from Drug Discovery, Professor Mukhopadhyay has worked on AI for environmental challenges, education, port and supply chain security, satellite image understanding, video and image analytics, design of intelligent buildings and transportation systems, wildfire prediction and detection, conservation of endangered species and intelligent cyber-physical-human systems, to name a few. His DeepSat framework for satellite imagery understanding forms the basis of NASA Earth Exchange (NEX) (see DeepSAT: A Deep Learning Approach to Tree-Cover Delineation in 1-m NAIP Imagery for the Continental United States - NASA Technical Reports Server (NTRS)).
In the last 13 years, Professor Mukhopadhyay has received more than $9 million in research grants. His research has been funded by the NSF, DARPA, ARO, ONR, NGA, NASA, DOE, USDOT, USDA, NRL, state agencies, and private industry. Professor Mukhopadhyay has published around 125 refereed publications in reputed journals and conferences. He has been awarded 3 US Patents and has 8 US patents pending. Additionally, he has received numerous awards for his research and cofounded a startup, Ailectric, for commercializing his research on sound, video, and image analytics (Ailectric | Home | Artificial Intelligence | Deep Learning). He serves as an associate editor for IEEE Transactions on Artificial Intelligence and Remote Sensing letters and has served in the program committees of AAAI.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- Summarize the basics of AI and other forms of computing;
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Antimicrobial Resistance (AMR) is a complex issue that needs to be tackled with a systems thinking approach, and interdisciplinary collaboration is key. The One Health Approach establishes that the health of humans, domestic and wild animals, plants, and the wider environment (including ecosystems) are closely linked and inter-dependent. Therefore, AMR should be addressed with a One Health approach in mind.
Animal health can broadly be divided into two sectors. The first sector is animal agriculture where a population medicine approach is used to address animal health issues, and where the main objective is to provide nutritious and healthy safe animal protein for the consumers.
In this session, attendees will gain an understanding of the veterinary perspective on ‘One Health’ system thinking, as well as learn about the current challenges and opportunities for antimicrobial stewardship in animal health, and how that ultimately affects the lives of humans.
Learning Objectives:
At the end of the session, the learner should be able to:
- Understand One Health from the veterinary perspective;
- Review the challenges around antibiotic use in animal health;
- Describe opportunities for antimicrobial stewardship in animal health.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Lucas Pantaleon DVM, MBA
Veterinary Industry Advisor
DVM One Health
Lucas Pantaleon, DVM, MBA, is a veterinarian and Board-Certified Large Animal Internal Medicine Specialist. He also holds an MBA and is the founder of DVM One Health. He works with companies and individuals to implement strategies to improve animal health by focusing on antibiotic use, infection prevention, One Health, and Value-Based veterinary care concepts in different sectors of animal health. Dr. Pantaleon also practices small animal general medicine. He is involved in different committees, councils, and Boards, working to better the health of pets and livestock. He enjoys researching, advising, teaching, speaking, and writing about infection prevention, AMR, and One Health for varied sectors within the veterinary industry and beyond. He lives in Kentucky with his wife and twin daughters.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Much of the focus of Antimicrobial Stewardship programs has been on optimizing use of antibiotics in bacterial infections. However, with the rising rates of antifungal resistance, antifungal stewardship is also necessary. Unlike antibacterial drugs, there are only a limited number of drugs available to treat invasive fungal infections. In this session, the audience will learn about the current epidemiology of antifungal resistance worldwide, the current limitations of antifungal therapy, the effects of COVID-19 pneumonia on the risk of fungal infections, and what antifungal stewardship steps could limit the rise of antifungal resistance.
Learning Objectives:
At the end of the session, the learner should be able to:
- Discuss the epidemiology of antifungal resistance and how it affects human health;
- Identify the main drivers for the increasing trend in antifungal resistance;
- Describe preventative measures to curb the development of antifungal resistance.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Emi Minejima, PharmD
Associate Professor of Clinical Pharmacy
USC School of Pharmacy
Dr. Minejima received her PharmD degree from University of California, San Diego Skaggs School of Pharmacy in 2005 and completed both her residency training in pharmacy practice and infectious diseases pharmacotherapy at Huntington Hospital in Pasadena, CA. After residency, she joined the faculty at the University of Southern California, School of Pharmacy where she is currently an Associate Professor of Clinical Pharmacy. Her clinical practice is based at Los Angeles County/USC Medical Center where she helps run the antimicrobial stewardship program and is the director for PGY2 infectious diseases residency program. Her research interests include S. aureus infections and optimizing the use of antibiotics to improve care for the medically underserved population.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- Discuss the epidemiology of antifungal resistance and how it affects human health;
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Antimicrobial stewardship is an important strategy to address the public health crisis of antimicrobial resistance. The emergence of telemedicine's use in a variety of innovative ways, especially during the COVID-19 pandemic, has allowed for antimicrobial stewardship programs to be implemented in settings with limited resources. In this session, the presenter will discuss the role of antimicrobial stewardship and its impact on antimicrobial resistance. Additionally, the presenter will provide a better understanding of telemedicine’s impact on antimicrobial usage.
Learning Objectives:
At the end of the session, the learner should be able to:
- Describe the role of antimicrobial stewardship on the impact of AMR;
- Understand the role of telemedicine on antimicrobial usage.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP
Chair of the Infectious Disease Division and Co-Director of Antimicrobial Stewardship
Summa Health
Thomas File, MD, MSc, MACP, FIDSA, FCCP, is Chair of the Infectious Disease Division and Co-Director of Antimicrobial Stewardship at Summa Health in Akron, Ohio. He is also a professor of Internal Medicine, Master Teacher, and Chair of the Infectious Disease Section at Northeast Ohio Medical University. After graduating from medical school at the University of Michigan, Ann Arbor, Dr. File received his Master of Science in medical microbiology from Ohio State University in Columbus, where he also completed his fellowship in infectious diseases.
Dr. File is a past President of the Board of Directors of the Infectious Diseases Society of America (IDSA) and Past President of the National Foundation for Infectious Diseases (NFID). He is a Master of the American College of Physicians, a fellow of the American College of Chest Physicians, and a member of the American Thoracic Society. He is also a past Chairperson of the Standards and Practice Guidelines Committee of the IDSA and served as a member of several guideline panels. Additionally, he is a past-president of the Infectious Disease Society of Ohio.
Dr. File’s primary research interests include respiratory tract infections, antimicrobial stewardship, immunizations in adults, and evaluation of new antimicrobial agents. A frequent lecturer, nationally and internationally, he has published more than 250 articles, abstracts, and textbook chapters, focusing on the diagnosis, etiology, and treatment of infectious diseases, especially on respiratory tract infections and antimicrobial stewardship. He received the Watanakunakorn Clinician Award from the IDSA in 2013 and the John P Utz Leadership award from NFID in 2017. He authors sections on community-acquired pneumonia, acute bronchitis, and hospital-acquired pneumonia in UpToDate. Dr. File is currently Editor-in-Chief of Infectious Diseases in Clinical Practice.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
Antimicrobial stewardship programs (ASPs) are a key component of addressing the global AMR threat. Optimizing the use and duration of in-hospital antimicrobials, along with organizational prioritization and buy-in, are just a few of the ASP strategies that can help lessen the burden of AMR.
The presenter will share more about the purpose of implementing an in-hospital ASP and discuss interventions that can be applied to improve antibiotic use, limiting AMR. Opportunities for how to align and integrate hospital sepsis programs with the ASP will also be discussed.
Learning Objectives:
At the end of the session, the learner should be able to:
- Understand the purpose of implementing an antimicrobial stewardship program in the hospital setting;
- Outline ASP interventions that can be applied to improve antibiotic use and limit antibiotic resistance;
- Discuss opportunities to align and integrate the hospital sepsis program with the ASP.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Nikunj Vyas, PharmD, BCPS
Clinical Pharmacist/Infectious Diseases
Jefferson Health - New Jersey
Nikunj Vyas, PharmD, BCPS, is a Clinical Pharmacy Specialist in Infectious Diseases currently practicing at Jefferson Health – New Jersey. He received his Doctorate of Pharmacy from St. John’s University in New York City in 2012. He then went on to complete a Pharmacy Practice Residency at Atlantic Health System in Morristown, NJ and Infectious Diseases Pharmacy Residency at West Virginia University Healthcare in Morgantown, West Virginia.
At Jefferson Health – New Jersey, Dr. Vyas oversees infectious disease pharmacotherapy and co-chairs the Antimicrobial Stewardship Committee, in collaboration with Infectious Diseases service. He also serves as a preceptor and mentor to post-doctoral pharmacy residents and students from numerous pharmacy schools. Additionally, Dr. Vyas serves as a member on numerous committees including the Sepsis Committee, the Infection Control Committee, and the Pharmacy and Therapeutics Committee, where he represents the Antimicrobial Stewardship Program and the Clinical Pharmacy Department.
Dr. Vyas is also well published in gram positive and gram-negative resistant organisms, as well as antimicrobial stewardship strategies in an inpatient setting. He has continued interest in patient quality and safety as well as clinical outcome-based research.
Dr. Vyas was awarded the Pharmacy Practitioner of the Year for the state of New Jersey in 2018 by New Jersey Health System Pharmacists. This big honor was for his dedication to Antimicrobial Stewardship and optimizing patient care. In his free time, Dr. Vyas is a sports fanatic and loves to travel and try different cuisines around the world.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
During this keynote session, Brad Spellberg, MD, a physician, researcher, and published author will discuss the scope of antimicrobial resistance in the 21st century. Dr. Spellberg will review the fundamental drivers of inappropriate antibiotic prescriptions and present some of his innovative solutions for improving antibiotic prescriptions.
Learning Objectives:
At the end of the session, the learner should be able to:
- Understand the scope of the antibiotic resistance problem;
- Learn the fundamental drivers of inappropriate antibiotic prescriptions;
- Learn some innovative solutions to improve antibiotic prescriptions.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Brad Spellberg, MD
Chief Medical Officer
LAC+USC Medical Center
Brad Spellberg, MD, is Chief Medical Officer (CMO) at the Los Angeles County-University of Southern California (LAC+USC) Medical Center. Dr. Spellberg has extensive administrative, patient care, and teaching activities. As CMO of LAC+USC Medical Center, one of the largest public hospitals in the U.S., he works to continuously improve the quality, safety, and efficiency of provided care. At LAC+USC Dr. Spellberg works on the Internal Medicine ward teams, Infectious Disease consulting service, and the Antibiotic Stewardship service. He also maintains an active NIH-funded basic science laboratory that focuses on novel solutions to combatting antibiotic–resistant infections. At the national level, Dr. Spellberg has worked extensively to bring attention to the problems of increasing drug resistance and decreasing new antibiotics. He works to raise attention of the need for national healthcare reform. Dr. Spellberg has testified before Congress and participated in numerous national meetings on antibiotic resistant superbugs and how to combat them, and has appeared in numerous media outlets discussing this issue. In 2009, he published the book Rising Plague to inform and educate the public about the crisis in antibiotic-resistant infections and lack of antibiotic development. His latest book, Broken, Bankrupt, and Dying: How to Solve the Great American Healthcare Rip-Off, was published in June 2020.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.9 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.75 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
With antimicrobial resistance as a growing global health concern, healthcare professionals across the continuum of care must educate themselves. Home healthcare nurses play an integral part in teaching their patients and their caregivers about preventing infection, conducting thorough assessments for infections, and collecting cultures as needed. In this session, the presenter will review and define antimicrobial resistance and stewardship globally and as it relates to the homecare setting. Attendees will also learn about antimicrobial stewardship strategies and responsibilities for the home healthcare nurse.
Learning Objectives:
At the end of the session, the learner should be able to:
- Identify the problem of antimicrobial resistance;
- Define antimicrobial stewardship (AMS);
- Examine AMS functions for the home healthcare nurse.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Lisa A. Gorski RN, MS, HHCNS-BC, CRNI, FAAN
Clinical Education Specialist
Ascension at Home
Lisa A. Gorski, RN, MS, HHCNS-BC, CRNI, FAAN has worked for over 35 years as a clinical nurse specialist (CNS) and educator for Wheaton Franciscan Home Health & Hospice, now part of Ascension at Home. She received both her bachelor's and master's degrees from the University of Wisconsin-Milwaukee College of Nursing.
Lisa is the author of more than 70 book chapters and journal articles and is the author of several books, including the 2023 edition of the Phillips Manual of IV Therapeutics: Evidence-Based Practice for Infusion Therapy. Lisa has been actively involved with the Infusion Nurses Society (INS) for many years serving as the chair of the INS Standards of Practice Committee from 2009 to 2021 and is the co-chair for the 2024 Standards. She speaks nationally and internationally on standards development, home healthcare, and infusion therapy/vascular access. She is the co-author of a 2021 article entitled “Antimicrobial Resistance and Antimicrobial Stewardship in Home Healthcare” published in Home Healthcare Now.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Recorded On: 04/26/2023
Part of Sepsis Alliance AMR Conference 2023
Description:
This session was part of the Sepsis Alliance AMR Conference 2023.
The role of nurses in caring for and improving outcomes for patients with infections and sepsis is well known. Beyond that, nurses can also directly impact antimicrobial resistance (AMR) and antimicrobial stewardship (AMS) through a variety of nurse-driven protocols and practices. These can include thorough assessments and allergy documentation, a questioning attitude towards culturing, evidence-based culturing techniques, and consideration for antimicrobial duration and route of administration. In this session, attendees will learn about the nurse’s role and responsibility in AMR and AMS, gain an understanding of opportunities and barriers to nurses’ engagement in AMS across the continuum of care, and examine key strategies to empower nurses’ ownership, accountability, and contribution to the core elements of AMS.
Learning Objectives:
At the end of the session, the learner should be able to:
- Discuss the nurse’s role and responsibility in AMR and AMS;
- Understand opportunities and barriers to nurses’ engagement in AMS across the continuum of care;
- Review key strategies to empower nurses’ ownership, accountability, and contribution to the core elements of antimicrobial stewardship.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Rita Olans, DNP, CPNP-PC, SNP, FAAN, FNAP
Associate Professor and Pediatric Track Coordinator, School of Nursing
MGH Institute of Health Professions
Rita Olans, DNP, CPNP-PC, SNP, FAAN, FNAP is a nationally recognized leader on nurses’ contributions to antimicrobial stewardship. She has authored numerous publications in nursing and medical literature and is a contributor to the National Quality Partners Playbooks for Antimicrobial Stewardship in Acute Care, in Post-Acute, and in Long-Term Care. Dr. Olans also served as a technical expert to the Agency for Healthcare Research and Quality Comprehensive Unit-based Safety Programs for Antimicrobial Stewardship in Acute Care and in Ambulatory Settings. She was a co-author of the ANA/CDC White Paper defining the nurse’s role in stewardship. She has been invited by The Joint Commission, the Pew Charitable Trust, the Centers for Disease Control and Prevention, the American Hospital Association, and the National Quality Forum to address how nurses contribute to antimicrobial stewardship. She is also a frequent presenter to physicians, nurses, nurse practitioners, pharmacists, microbiologists, public health officials, and regulatory agencies.
Dr. Olans is an Associate Professor at the MGH Institute of Health Professions and a Fellow of the American Academy of Nursing.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 0.8 contact hours.
Other healthcare professionals will receive a certificate of attendance for 0.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.